Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Precose (acarbose) Tablets, Bayer NDA 20-482/S-011 10/29/02 11/18/02 | Precose (acarbose) Tablets, Bayer NDA 20-482/S-010 8/16/99 5/19/00 | Precose (acarbose) Tablets, Bayer Pharmaceutical Division NDA 20-482/S-007 and S-008 9/29/98 9/29/98 12/11/98 | Precose Indications: S-007- provided for the new combination use of Precose for patients with type 2 diabetes treated with diet plus insulin; and S-008- provided for the new combination of Precose for patients with type 2 diabetes with diet and metformin. | Precose (acarbose) Tablets, Bayer Pharma, Labeling Revision | Acarbose Tablets, Roxane Laboratories, Inc., Approval | Acarbose Tablets, Cobalt Laboratories, Approval | Precose (acarbose) Tablets, Bayer HealthCare Pharmaceuticals, Labeling Revision | Acarbose Tablets, IMPAX Laboratories, Inc., Approval | Acarbose Tablets, Mylan Pharmaceuticals, Inc., Approval | Precose (acarbose) Tablets, Bayer HealthCare Pharmaceuticals, Labeling Revision | Acarbose Tablets, Strides Arcolab, Ltd., Approval ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com